Characterization of RBD-specific cross-neutralizing antibodies responses against SARS-CoV-2 variants from COVID-19 convalescents

Overview of attention for article published in Frontiers in immunology, May 2023

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (72nd percentile)
High Attention Score compared to outputs of the same age and source (85th percentile)

Mentioned by

twitter: 4 X users

patent: 1 patent

Readers on

mendeley: 9 Mendeley

Summary X Patents

So far, Altmetric has seen 1 patent that references this research output.

ANTIGEN BINDING MOLECULES TARGETING SARS-COV-2

Application WO-2024102674-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.